Recombinant Human Interleukin-3 in Patients with Hematopoietic Failure

  • A. Ganser
  • A. Lindemann
  • G. Seipelt
  • O. G. Ottmann
  • M. Eder
  • F. Herrmann
  • J. Frisch
  • G. Schulz
  • R. Mertelsmann
  • D. Hoelzer
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 121)


Infections and bleeding are the most frequent causes of death in patients with bone marrow failure secondary to chemotherapy and/or radiotherapy for malignant disease. Treatment of anemia and severe thrombocytopenia has hitherto depended solely on red blood cell and platelet transfusion. With the recent availability of recombinant hematopoietic colony-stimulating factors (CSFs), stimulation of hematopoiesis in vivo has evolved as a new, potentially efficacious treatment modality. The feasibility of this approach is supported by several clinical studies showing that two distinct CSFs, granulocyte-macrophage CSF (GM-CSF) and granulocyte CSF (G-CSF), can indeed elevate total leukocyte counts in patients with bone marrow failure [1–14]. However, improvements in erythropoiesis and thrombopoiesis were observed only sporadically [2, 6, 7, 8].


Myelodysplastic Syndrome Reticulocyte Count Bone Marrow Failure Hematopoietic Growth Factor Hematopoietic Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Groopman JE, Mitsuyasu RT, DeLeo MJ, Oette DH, Golde DW (1987) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 317: 593–598PubMedCrossRefGoogle Scholar
  2. 2.
    Vadhan-Raj S, Keating M, LeMaistre A, Hittelmann WN, McCredie K, Trujillo JM, Broxmeyer HE, Henney C, Gutterman JU (1987) Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 317: 1545–1552PubMedCrossRefGoogle Scholar
  3. 3.
    Antin JH, Smith BR, Holmes W, Rosenthal DS (1988) Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 72: 705–713PubMedGoogle Scholar
  4. 4.
    Vadhan-Raj S, Buescher S, Broxmeyer HE, LeMaistre A, Lepe-Zuniga JL, Ventura G, Jeha S, Horwitz L, Trujillo JM, Gillis S, Hittelman WN, Gutterman JU (1988) Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N Engl J Med 319: 1628–1634PubMedCrossRefGoogle Scholar
  5. 5.
    Vadhan-Raj S, Buescher S, LeMaistre A, Keating M, Walters R, Ventura C, Hittelman W, Broxmeyer HE, Gutterman JU (1988) Stimulation of hematopoietis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. Blood 72: 134–141PubMedGoogle Scholar
  6. 6.
    Ganser A, Voelkers B, Greher J, Ottman OG, Walther F, Becher R, Bergmann L, Schulz G, Hoelzer D (1989) Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes — a phase I/II study. Blood 73: 31–37PubMedGoogle Scholar
  7. 7.
    Thompson JA, Lee DJ, Kidd P, Rubin E, Kaufmann J, Bonnem EM, Fefer A (1989) Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics and hematological effects. J Clin Oncol 7: 629–637PubMedGoogle Scholar
  8. 8.
    Ganser A, Ottmann OG, Erdmann H, Schulz G, Hoelzer D (1989) The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. Ann Intern Med 111: 887–892PubMedGoogle Scholar
  9. 9.
    Herrmann F, Lindemann A, Klein H, Lubbert M, Schulz G, Mertelsmann R (1988) Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts. Leukemia 3: 355–338Google Scholar
  10. 10.
    Negrin RS, Haeuber DH, Nagler A, Olds LC, Donlon T, Souza LM, Greenberg PL (1989) Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial. Ann Intern Med 110: 976–984Google Scholar
  11. 11.
    Glaspy JA, Baldwin GC, Robertson PA, Souza L, Vincent M, Ambersley J, Golde DW (1988) Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Intern Med 109: 789–795PubMedGoogle Scholar
  12. 12.
    Kobayashi Y, Okabe T, Ozawa K, Chiba S, Hino M, Miyazono K, Urabe A, Takaku F (1989) Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report. Am J Med 86: 178–182PubMedCrossRefGoogle Scholar
  13. 13.
    Jakubowski AA, Souza L, Kelly F et al. (1989) Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med 320: 38–42PubMedCrossRefGoogle Scholar
  14. 14.
    Bonilla MA, Gillio AP, Ruggeiro M, Kernan NA, Brochstein JA, Abboud M, Fumagalli L, Vincent M, Gabrilove JL, Welte K, Souza LM, O’Reilly RJ (1989) Effects of recombinant human granulocyte colony-stimulating factor in patients with congenital agranulocytosis. N Engl J Med 320: 1574–1580PubMedCrossRefGoogle Scholar
  15. 15.
    Ihle J, Keller J, Oroszlan S, Henderson LE, Copeland TD, Fitch F, Prystowsky MB, Goldwasser E, Schrader JW, Palazynski E, Dy M, Lebel B (1983) Biologic properties of homogenous interleukin 3. J Immunol 131: 282–287PubMedGoogle Scholar
  16. 16.
    Leary AG, Yang YC, Clark SC, Gasson JC, Golde DW, Ogawa M (1987) Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 70: 1343–1348PubMedGoogle Scholar
  17. 17.
    Saeland S, Caux C, Favre C, Aubry LP, Mannoni P, Pebusque MJ, Gentilhomme O, Otsuka T, Ykotay T, Arai N, Banchereau J, de Vries JE (1988) Effects of recombinant human interleukin 3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. Blood 72: 1580–1588Google Scholar
  18. 18.
    Sonoda Y, Yang YC, Wong GG, Clark SC, Ogawa M (1988) Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte-macrophage colony-stimulating factor are specific for early development stages. Proc Natl Acad Sci USA 85: 4360–4363PubMedCrossRefGoogle Scholar
  19. 19.
    Rothenberg ME, Owen WF Jr, Silberstein DS, Woods J, Sobermann RJ, Austen KF, Stevens RL (1988) Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 81: 1986–1992PubMedCrossRefGoogle Scholar
  20. 20.
    Lopez AF, Dyson PG, To LB, Elliott J, Milton SE, Russell JA, Juttner CA, Yang YC, Clark SC, Vadas MA (1988) Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness in differentiation in the neutrophilic myeloid series. Blood 72: 1797–1804PubMedGoogle Scholar
  21. 21.
    Cannistra SA, Vellenga E, Groshek P, Rambaldi A, Griffin JD (1988) Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate mono-cyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 71: 672–676PubMedGoogle Scholar
  22. 22.
    Lopez AF, To LB, Yang Y-C, Gamble JR, Shannon MF, Burns GF, Dyson PG, Juttner CA, Clark S, Vadas MA (1987) Stimulation of proliferation, differentiation and function of human cells by primate interleukin 3. Proc Natl Acad Sci USA 84: 2761–2765PubMedCrossRefGoogle Scholar
  23. 23.
    Emerson SG, Yang YC, Clark SC, Long MW (1988) Human recombinant granulocyte-macrophage colony-stimulating factors and interleukin 3 have overlapping but distinct hematopoietic activities. J Clin Invest 82: 1282–1287PubMedCrossRefGoogle Scholar
  24. 24.
    Bruno R, Briddell R, Hoffman R (1988) Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. Exp Hematol 16: 371–377PubMedGoogle Scholar
  25. 25.
    Lu L, Briddell RA, Graham CD, Brandt JE, Bruno E, Hoffman R (1988) Effect of recombinant and purified human haematopoietic growth factors on in vitro colony formation by enriched populations of human megakaryocyte progenitor cells. Br J Haematol 70: 149–156PubMedCrossRefGoogle Scholar
  26. 26.
    Teramura M, Katahira J, Hoshino S, Motoji T, Oshimi K, Mizoguchi H (1988) Clonal growth of human megakaryocyte progenitors in serum-free cultures: effect of recombinant human interleukin-3 Exp Hematol 16: 843–848Google Scholar
  27. 27.
    Kindler V, Thorens B, de Kossodo S, Allet B, Eliason JF, Thatcher D, Farber N, Vassalli P (1986) Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3. Proc Natl Acad Sci USA 83: 1001–1005PubMedCrossRefGoogle Scholar
  28. 28.
    Metcalf D, Begley CG, Johnson GR, Nicola NA, Lopez AF, Williamsen DJ (1986) Effects of purified bacterially synthezised murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood 68: 46–57PubMedGoogle Scholar
  29. 29.
    Broxmeyer HE, Williams D, Hangoc G, Cooper S, Gillis S, Shadduck RK, Bicknell DC (1987) Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin-3, and recombinant murine granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci USA 84: 3871–3875PubMedCrossRefGoogle Scholar
  30. 30.
    Donahue RE, Seehra J, Metzger M, Lefebvre D, Rock B, Carbone S, Nathan DG, Garnick M, Sehgal PK, Laston D, la Vallie E, McCoy J, Schendel PF, Norton C, Turner K, Yang YC, Clark SC (1988) Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 241: 1820–1823PubMedCrossRefGoogle Scholar
  31. 31.
    Krumwieh D, Seiler FR (1989) In vivo effects of recombinant colony stimulating factors on hematopoiesis in cynamolgus monkeys. Transplant Proc 21: 379–383Google Scholar
  32. 32.
    Mayer P, Valent P, Schmidt G, Liehl E, Bettelheim P (1989) The in vivo effect of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity and priming of GM-CSF-responsive progenitors in nonhuman primates. Blood 74: 613–621PubMedGoogle Scholar
  33. 33.
    Yang Y-C, Charletta AB, Temple PA, Chung MP, Kovacic S, Witek-Giannotti JS, Leary AC, Kriz R, Donahue RE, Wong GG, Clark SC (1986) Human IL-3 (multiCSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 47: 3–10PubMedCrossRefGoogle Scholar
  34. 34.
    Dorssers L, Burger H, Bot F, Delwel R, van Kessel HMG, Löwenberg B, Wagemaker G (1987) Characterization of a human multilineage colony-stimulating factor cDNA clone identified by a conserved noncoding sequence in mouse interleukin-3. Gene 55: 115–124PubMedCrossRefGoogle Scholar
  35. 35.
    Gillis G, Urdal DL, Clergenger W, Kluske R, Sassenfeld H, Price V, Cosman D (1988) Production of recombinant human colony stimulating factors in yeast. Behring Inst Mitt 83: 1–7PubMedGoogle Scholar
  36. 36.
    Otsuka T, Miyajima A, Brown N, Otsu K, Abrams J, Saeland S, Caux C, Malefijt RDW, De Vries R, Meyerson P, Yokota K, Gemmel L, Rennick D, Lee F, Arai N, Arai KI, Yokota T (1988) Isolation and characterization of an expressible cDNA encoding human IL-3. Induction of IL-3 mRNA in human T cell clones. J Immunol 140: 2288–2295PubMedGoogle Scholar
  37. 37.
    Miller AB, Hoogstraaten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 201–206Google Scholar
  38. 38.
    Migliaccio AR, Migliaccio G, Adamson JW (1988) Effect of recombinant hemopoietic growth factors on proliferation of human marrow progenitor cells in serum-deprived liquid culture. Blood 72: 1387–1392PubMedGoogle Scholar
  39. 39.
    Messner HA, Yamasadi K, Jamal N, Minden MM, Yang YC, Wong GG, Clark SC (1987) Growth of human hemopoietic colonies in response to recombinant gibbon interleukin-3: comparison with human granulocyte and granulocyte-macrophage colony-stimulating factor: Proc Natl Acad Sci USA 84: 6765–6769PubMedGoogle Scholar
  40. 40.
    Tadmori W, Feingersh D, Clark SC, Choi YS (19.89) Human recombinant IL-3 stimulates B cell differentiation. J Immunol 142: 1950–1955Google Scholar
  41. 41.
    Berdel WE, Danhauser-Riedl S, Steinhauser G, Winton EF (1989) Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73: 80–83Google Scholar
  42. 42.
    Anderson KC, Jones RM, Morimoto C, Leavitt P, Barut BA (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 73: 1915–1924PubMedGoogle Scholar
  43. 43.
    Delwel R, Dorssers I, Touw I, Wagemaker G, Löwenberg B (1987) Human recombinant multilineage colony stimulating factor: stimulation of acute myelocytic leukemia progenitor cells in vitro. Blood 70: 333–336PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1991

Authors and Affiliations

  • A. Ganser
    • 1
  • A. Lindemann
    • 2
  • G. Seipelt
    • 1
  • O. G. Ottmann
    • 1
  • M. Eder
    • 1
  • F. Herrmann
    • 2
  • J. Frisch
    • 3
  • G. Schulz
    • 3
  • R. Mertelsmann
    • 2
  • D. Hoelzer
    • 1
  1. 1.Abteilung für Hämatologie, Zentrum der Inneren MedizinKlinikum der Johann Wolfgang Goethe-UniversitätFrankfurt 70Germany
  2. 2.Abteilung Hematologie-OnkologieMedizinische UniversitätsklinikFreiburgGermany
  3. 3.Klinische ForschungBehringwerke AGMarburgGermany

Personalised recommendations